IMNN ▲ +5.2% - Imunon, Inc. $IMNN - IMUNON Enters Cooperative Research and Development Agreement with National Cancer Institute to Advance Clinical Development of IMNN-001 Imunon shares rose 5.2% today following the company's announcement of a cooperative research and development agreement with the National Cancer Institute to advance clinical development of its lead candidate IMNN-001. The partnership with a major government research institution suggests validation of the therapeutic approach and potential to accelerate the drug's path toward clinical milestones. 10-SEP-2026 09:30 AM ET